Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$3.77
$0.3359.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.66M | 4.08M | 3.86M | 2.76M | 2.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.26M | 7.70M | 7.20M | 5.75M | 5.73M |
| Operating Income | -9.26M | -7.70M | -7.20M | -5.75M | -5.73M |
| Income Before Tax | -10.47M | -9.14M | -9.19M | -7.20M | -7.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.47 | -9.14 | -9.19 | -7.20 | -7.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.47M | -9.14M | -9.19M | -7.20M | -7.35M |
| EBIT | -9.26M | -7.70M | -7.20M | -5.75M | -5.73M |
| EBITDA | -9.26M | -7.69M | -7.20M | -5.74M | -5.73M |
| EPS Basic | -79.53 | -92.79 | -105.11 | -88.18 | -94.73 |
| Normalized Basic EPS | -44.89 | -52.66 | -60.78 | -54.84 | -54.98 |
| EPS Diluted | -81.41 | -94.66 | -105.11 | -88.18 | -94.73 |
| Normalized Diluted EPS | -44.89 | -52.66 | -60.78 | -54.84 | -54.98 |
| Average Basic Shares Outstanding | 778.10K | 459.10K | 342.80K | 326.20K | 313.20K |
| Average Diluted Shares Outstanding | 778.10K | 459.10K | 342.80K | 326.20K | 313.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |